-
Pharmacotherapy of Head and Neck Cancer
Expert Opinion Pharmacotherapy, 2015
-
Early and Severe Radiation Toxicity Associated with Concurrent Sirolimus in an Organ Transplant Recipient with Head and Neck Cutaneous Squamous Cell Carcinoma: A Case Report
Anticancer Research, 2015
-
Effect of Human Papillomavirus on Patterns of Distant Metastatic Failure in Oropharyngeal Squamous Cell Carcinoma Treated With Chemoradiotherapy
JAMA Otolaryngol Head Neck Surg, 2015
-
Impact of Feeding Tube Choice on Severe Late Dysphagia After Definitive Chemoradiotherapy for Human Papillomavirus-Negative Head and Neck Cancer
Head Neck, 2015
-
In Squamous Cell Head and Neck Cancer: Which Platinum, How much and How Often?
Expert Review of Anticancer Therapy, 2014
-
Solitary Dural Metastasis at Presentation in a Patient With Untreated Human Papillomavirus Associated Squamous Cell Carcinoma of the Oropharynx
Head and Neck, 2013
-
Head and Neck Cancer
Expert Clinical Perspective on Diagnosis & Management of Cancer Analysis of Controversies & Uncertainties in Cancer, 2013
-
Molecular Biology of Lung Cancer and Therapeutic Implications
Emerging Cancer Therapeutics, 2012
-
Chemotherapy & Targeted Therapy in Head & Neck Cancer
Head & Neck Oncology Multidisciplinary Approach to Head & Neck Neoplasms, 2012
-
The Role of Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
Seminars in Radiation Oncology, 2012
-
Outcomes of Induction Chemotherapy Followed by Concurrent Chemoradiation for Nasopharyngeal Carcinoma
Oral Oncology, 2012
-
Biomarkers in Lung Cancer
Advances in Personalized Therapy for Lung Cancer, 2011
-
Crizotinib (PF02341066) as a ALK/MET inhibitor- Special Emphasis as a Therapeutic Drug Against Lung Cancer
Drugs of the Future, 2011
-
Pharmacodynamic and Predictive Biomarkers for VEGF and mTOR
Directed Therapies, 2010